These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 18183056)

  • 1. [Treatment of osteoporosis with parathyroid hormone].
    Syversen U; Halse JI
    Tidsskr Nor Laegeforen; 2008 Jan; 128(1):39-41. PubMed ID: 18183056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Parathyroid and bone. Evidence and perspective of parathyroid therapy for patients with osteoporosis].
    Wada S; Fukawa T; Kamiya S
    Clin Calcium; 2007 Dec; 17(12):1888-94. PubMed ID: 18057665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of osteoporosis with parathyroid hormone and teriparatide.
    Pleiner-Duxneuner J; Zwettler E; Paschalis E; Roschger P; Nell-Duxneuner V; Klaushofer K
    Calcif Tissue Int; 2009 Mar; 84(3):159-70. PubMed ID: 19189037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anabolic treatment for osteoporosis: PTH treatment].
    Kaji H; Sugimoto T
    Clin Calcium; 2006 Sep; 16(9):1480-85. PubMed ID: 16951472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Parathyroid and bone. Role of parathyroid hormone in the treatment of osteoporosis].
    Nakamura T
    Clin Calcium; 2007 Dec; 17(12):1823-9. PubMed ID: 18057656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of anabolic and antiresorptive agents for the treatment of osteoporosis.
    Garcés C; García LE
    Maturitas; 2006 Apr; 54(1):47-54. PubMed ID: 16257150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost effectiveness of teriparatide and PTH(1-84) in the treatment of postmenopausal osteoporosis.
    Borgström F; Ström O; Marin F; Kutahov A; Ljunggren O
    J Med Econ; 2010; 13(3):381-92. PubMed ID: 20604678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: an 18-month, multicenter, open-label, prospective study.
    Adachi JD; Hanley DA; Lorraine JK; Yu M
    Clin Ther; 2007 Sep; 29(9):2055-67. PubMed ID: 18035204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid hormone update.
    Hamann KL; Lane NE
    Rheum Dis Clin North Am; 2006 Nov; 32(4):703-19. PubMed ID: 17288973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTH analogues and osteoporotic fractures.
    Verhaar HJ; Lems WF
    Expert Opin Biol Ther; 2010 Sep; 10(9):1387-94. PubMed ID: 20629581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Teriparatide: an anabolic drug for the treatment of patients with osteoporosis].
    Lems WF; Hamdy NA; Netelenbos JC
    Ned Tijdschr Geneeskd; 2006 Jan; 150(3):132-7. PubMed ID: 16463613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parathyroid hormone as an anabolic therapy for women and men.
    Bilezikian JP; Rubin MR; Finkelstein JS
    J Endocrinol Invest; 2005; 28(8 Suppl):41-9. PubMed ID: 16329201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of parathyroid hormone alone or in combination with antiresorptive therapy on bone mineral density and fracture risk--a meta-analysis.
    Vestergaard P; Jorgensen NR; Mosekilde L; Schwarz P
    Osteoporos Int; 2007 Jan; 18(1):45-57. PubMed ID: 16951908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Parathyroid hormone for osteroporsis: why and who to treat?].
    Ferrari S; Rizzoli R
    Rev Med Suisse; 2005 Oct; 1(35):2272-4, 2276-7. PubMed ID: 16268450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential of parathyroid hormone as a therapy for osteoporosis.
    Rubin MR; Bilezikian JP
    Int J Fertil Womens Med; 2002; 47(3):103-15. PubMed ID: 12081255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parathyroid hormone (1-84) and treatment of osteoporosis.
    Shrader SP; Ragucci KR
    Ann Pharmacother; 2005 Sep; 39(9):1511-6. PubMed ID: 16076911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two osteoporosis treatments deemed best for brittle bones. Sequential therapy of two drugs, bisphosphonates and PTH, produces the best effects on bone strength.
    Health News; 2006 Feb; 12(2):3-4. PubMed ID: 16453932
    [No Abstract]   [Full Text] [Related]  

  • 18. [Austrian guidance for the pharmacological treatment of osteoporosis in postmenopausal women--update 2009].
    Dimai HP; Pietschmann P; Resch H; Preisinger E; Fahrleitner-Pammer A; Dobnig H; Klaushofer K;
    Wien Med Wochenschr Suppl; 2009; (122):1-34. PubMed ID: 19484202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential therapy in the treatment of osteoporosis.
    Boonen S; Milisen K; Gielen E; Vanderschueren D
    Curr Med Res Opin; 2011 Jun; 27(6):1149-55. PubMed ID: 21466276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTH increases jaw mineral density in a rabbit model of osteoporosis.
    Bellido M; Lugo L; Castañeda S; Roman-Blas JA; Rufián-Henares JA; Navarro-Alarcón M; Largo R; Herrero-Beaumont G
    J Dent Res; 2010 Apr; 89(4):360-5. PubMed ID: 20177133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.